Iqvia Holdings (IQV) Depreciation & Amortization (CF) (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Depreciation & Amortization (CF) came in at $288.0 million in Q1 2026, up 8.68% year-on-year from $265.0 million in Q1 2025, and down 9.15% quarter-over-quarter from $317.0 million in Q4 2025.
Iqvia Holdings (IQV) Depreciation & Amortization (CF) (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Depreciation & Amortization (CF) across 15 years of filings, most recently posting $288.0 million for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $288.0 million, up 8.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 4.66% YoY), and the FY2025 annual result was $1.1 billion, up 2.69% from the prior year.
- Depreciation & Amortization (CF) came in at $288.0 million for Q1 2026 at Iqvia Holdings, down from $317.0 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $357.0 million in Q4 2022 to a low of $248.0 million in Q3 2022.
- The 5-year median for Depreciation & Amortization (CF) is $276.0 million (2025), against an average of $282.4 million.
- Peak annual rise in Depreciation & Amortization (CF) reached 36.26% in 2022, while the deepest fall reached 26.19% in 2022.
- Iqvia Holdings' Depreciation & Amortization (CF) stood at $357.0 million in 2022, then slipped by 11.48% to $316.0 million in 2023, then slipped by 4.11% to $303.0 million in 2024, then grew by 4.62% to $317.0 million in 2025, then fell by 9.15% to $288.0 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $288.0 million (Q1 2026), $317.0 million (Q4 2025), and $286.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 36.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 306.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 193.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 37.68 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 67.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 14.52 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 288.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 51.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 13.16 Mn |
| 10 | Quest Diagnostics | 22.51 Bn | 22.42 Bn | 942.00 Mn | 147.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 288.00 Mn |
| Mar 31, 2026 | 288.00 Mn |
| Dec 31, 2025 | 317.00 Mn |
| Dec 31, 2025 | 317.00 Mn |
| Sep 30, 2025 | 286.00 Mn |
| Sep 30, 2025 | 286.00 Mn |
| Jun 30, 2025 | 276.00 Mn |
| Jun 30, 2025 | 276.00 Mn |
| Mar 31, 2025 | 265.00 Mn |
| Mar 31, 2025 | 265.00 Mn |
| Dec 31, 2024 | 303.00 Mn |
| Dec 31, 2024 | 303.00 Mn |
| Sep 30, 2024 | 278.00 Mn |
| Sep 30, 2024 | 278.00 Mn |
| Jun 30, 2024 | 269.00 Mn |
| Jun 30, 2024 | 269.00 Mn |
| Mar 31, 2024 | 264.00 Mn |
| Mar 31, 2024 | 264.00 Mn |
| Dec 31, 2023 | 316.00 Mn |
| Dec 31, 2023 | 316.00 Mn |